Suppression of PHLPP2 or FOXO1, followed with dysregulation of p21, p27, CyclinD1 and Ki67, play critical roles during miR-135a-mediated bladder cancer cells proliferation. The gene discussed is CCND1; the disease is urinary bladder cancer.